About Earum Pharmaceuticals
Earum Pharmaceuticals is a company based in Ahmedabad (India) founded in 2012. Earum Pharmaceuticals operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Ahmedabad, India
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Murae Organisor Limited
-
Annual Revenue
$100.08 M (USD)26594.83as on Mar 31, 2025
-
Net Profit
$880.1 K (USD)14060.64as on Mar 31, 2025
-
EBITDA
$1.17 M (USD)0as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Earum Pharmaceuticals
Earum Pharmaceuticals is a publicly listed company on the BSE with ticker symbol MURAE in India, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Earum Pharmaceuticals
Detailed funding history for Earum Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Earum Pharmaceuticals
Investment portfolio details for Earum Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Earum Pharmaceuticals
Detailed financials for Earum Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Earum Pharmaceuticals Comparisons
Peer comparison for Earum Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Earum Pharmaceuticals
Earum Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of Earum Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Earum Pharmaceuticals
Complete news archive for Earum Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Earum Pharmaceuticals
Earum Pharmaceuticals was founded in 2012.
Earum Pharmaceuticals is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Annual revenue of Earum Pharmaceuticals is $100.08M as on Mar 31, 2025.
Earum Pharmaceuticals was established in 2012 in Ahmedabad, India, within the pharmaceutical sector. Formulation products are produced as the primary operations. The company focuses on manufacturing activities for pharmaceutical needs. Leadership is held by Managing Director Bhumishth Patel. The domain earumpharma.com is maintained for online presence. Geographic operations are centered in India, supporting local and potential broader markets.
Earum Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Yes, Earum Pharmaceuticals is publicly traded on BSE under the ticker symbol MURAE.
The ticker symbol of Earum Pharmaceuticals is MURAE on BSE.